Date | Insider | Price | Amount |
---|---|---|---|
4-3-2017 Insider Buy |
David Ian Johnson President and CEO |
$0.40 CAGR » |
$100,000.00 250,000 shares |
4-3-2017 Insider Buy |
Pellegrino Pionati See Remarks |
$0.40 CAGR » |
$20,000.00 50,000 shares |
4-3-2017 Insider Buy |
Joseph M. Leone Director |
$0.40 CAGR » |
$10,000.00 25,000 shares |
4-3-2017 Insider Buy |
Bradford Barton Chief Operating Officer |
$0.40 CAGR » |
$30,000.00 75,000 shares |
4-3-2017 Insider Buy |
Mark T. Wagner Director |
$0.40 CAGR » |
$25,000.00 62,500 shares |
2-27-2017 Insider Buy |
Corp /DE/ Celgene >10% Owner |
$0.50 CAGR » |
$2,000,000.00 4,000,000 shares |
2-27-2017 Insider Buy |
Jerome B. Zeldis Director |
$0.50 CAGR » |
$200,000.00 400,000 shares |
11-6-2015 Insider Buy |
Jeffrey Sklar Director |
$2.95 CAGR » |
$4,425.00 1,500 shares |
11-9-2015 Insider Buy |
Brian M. Posner Chief Financial Officer |
$3.04 CAGR » |
$15,200.00 5,000 shares |
11-6-2015 Insider Buy |
Bradford Barton Chief Operating Officer |
$2.97 CAGR » |
$14,850.00 5,000 shares |
11-6-2015 Insider Buy |
Pellegrino Pionati Chief Strategy & Marketing Off |
$2.95 CAGR » |
$29,500.00 10,000 shares |
11-6-2015 Insider Buy |
Jerome B. Zeldis Director |
$2.91 CAGR » |
$40,740.00 14,000 shares |
11-6-2015 Insider Buy |
Mark T. Wagner Director |
$2.88 CAGR » |
$23,040.00 8,000 shares |
11-6-2015 Insider Buy |
Joseph M. Leone Director |
$2.78 CAGR » |
$9,730.00 3,500 shares |
11-6-2015 Insider Buy |
David Ian Johnson President and CEO |
$2.92 CAGR » |
$25,258.00 8,650 shares |
8-10-2015 Insider Buy |
Brian M. Posner Chief Financial Officer |
$5.02 CAGR » |
$12,550.00 2,500 shares |
6-8-2015 Insider Buy |
Bradford Barton Chief Operating Officer |
$5.25 CAGR » |
$15,735.00 3,000 shares |
5-27-2015 Insider Buy |
David Ian Johnson President and CEO |
$4.65 CAGR » |
$46,458.00 10,000 shares |
5-20-2015 Insider Buy |
Brian M. Posner Chief Financial Officer |
$4.34 CAGR » |
$10,850.00 2,500 shares |
5-4-2015 Insider Buy |
Corp /DE/ Celgene >10% Owner |
$4.55 CAGR » |
$2,999,997.00 659,340 shares |
9-15-2014 Insider Buy |
Brian M. Posner Chief Financial Officer |
$4.94 CAGR » |
$9,880.00 2,000 shares |
5-13-2014 Insider Buy |
Brian M. Posner Chief Financial Officer |
$6.92 CAGR » |
$20,760.00 3,000 shares |
4-14-2014 Insider Buy |
Corp /DE/ Celgene >10% Owner |
$7.00 CAGR » |
$5,000,002.00 714,286 shares |
5-21-2013 Insider Buy |
Kenneth L. Londoner Director |
$0.07 CAGR » |
$15,059.00 219,500 shares |
Also See: Institutional Holders of ALQA
Also See: SEC filings
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 04/04/2017 | |
End date: | 05/03/2019 | |
Start price/share: | $4.70 | |
End price/share: | $2.69 | |
Dividends collected/share: | $0.00 | |
Total return: | -42.77% | |
Average Annual Total Return: | -23.54% | |
Starting investment: | $10,000.00 | |
Ending investment: | $5,722.78 | |
Years: | 2.08 |
ALQA Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent ALQA insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding ALQA
Free ALQA Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |